Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2023 07:00 ET | Source: Renalytix AI, Inc.

Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

LONDON and SALT LAKE CITY, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the execution of a Co-operative Research and Development Agreement (CRADA) with...
December 01, 2022 07:00 ET | Source: Renalytix AI, Inc.

Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes

LONDON and SALT LAKE CITY, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced additional highlights from the publication of data from a clinical utility study...
November 30, 2022 07:00 ET | Source: Renalytix AI, Inc.

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...
November 29, 2022 07:00 ET | Source: Renalytix AI, Inc.

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

Risk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an observed reduction of HbA1c levels in the...
November 22, 2022 07:00 ET | Source: Renalytix plc

Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30

LONDON and SALT LAKE CITY, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2023 financial results on Wednesday,...
November 03, 2022 07:00 ET | Source: Renalytix plc

Renalytix to Present at Stifel Healthcare Conference

NEW YORK and SALT LAKE CITY, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will participate in the Stifel Healthcare Conference to be held...
October 31, 2022 07:00 ET | Source: Renalytix plc

Renalytix Reports Full Year Fiscal 2022 Results

LONDON and SALT LAKE CITY, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...
October 24, 2022 07:00 ET | Source: Renalytix plc

Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2022 on October 31

NEW YORK and SALT LAKE CITY, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its fourth quarter and full year fiscal 2022 financial...
October 17, 2022 07:00 ET | Source: Renalytix plc

KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology

NEW YORK and SALT LAKE CITY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that four scientific presentations have been accepted at the upcoming American...
September 20, 2022 07:00 ET | Source: Renalytix plc

Renalytix Announces Change to Board of Directors

LONDON and SALT LAKE CITY, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that Ann Berman, non-executive director and chair of the audit and nomination...